Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950136-06-003331
Filing Date
2006-05-01
Accepted
2006-05-01 17:06:12
Documents
8
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A file001.htm 10-K/A 237624
2 GRAPHIC ebox.gif GRAPHIC 58
3 GRAPHIC html_02402newchart.jpg GRAPHIC 52699
4 GRAPHIC spacer.gif GRAPHIC 43
5 GRAPHIC xbox.gif GRAPHIC 63
6 CERTIFICATION file002.htm EX-31.1 11706
7 CERTIFICATION file003.htm EX-31.2 11700
8 CERTIFICATION file004.htm EX-32.1 4287
  Complete submission text file 0000950136-06-003331.txt   340274
Mailing Address 150 JOHN F. KENNEDY PARKWAY SUITE 100 SHORT HILLS NJ 07078
Business Address 150 JOHN F. KENNEDY PARKWAY SUITE 100 SHORT HILLS NJ 07078 44 1382 207506
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-50626 | Film No.: 06796025
SIC: 2834 Pharmaceutical Preparations